- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Zika Virus Vaccines market will register a 3.1%% CAGR in terms of revenue, the global market size will reach $ 14380 million by 2025, from $ 12750 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Zika Virus Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Zika Virus Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Zika Virus Vaccines, covering the supply chain analysis, impact assessment to the Zika Virus Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Zika Virus Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
DNA Vaccine
Inactivated Vaccine
Purified Inactivated Vaccine
Table of Contents
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Academic and Research
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
NHI
Intrexon Corp.
Sanofi
Bharat.
Takeda
GSK
PaxVax
Inovio Pharmaceuticals
Gilead Sciences Inc.
GeneOne Life Science Inc
NewLink Genetics Corp
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Zika Virus Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Zika Virus Vaccines market by identifying its various subsegments.
Focuses on the key global Zika Virus Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Zika Virus Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Zika Virus Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Zika Virus Vaccines Consumption 2015-2025
2.1.2 Zika Virus Vaccines Consumption CAGR by Region
2.2 Zika Virus Vaccines Segment by Type
2.2.1 DNA Vaccine
2.2.2 Inactivated Vaccine
2.2.3 Purified Inactivated Vaccine
2.2.4 Table of Contents
2.3 Zika Virus Vaccines Consumption by Type
2.3.1 Global Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Zika Virus Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Zika Virus Vaccines Sale Price by Type (2015-2020)
2.4 Zika Virus Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Academic and Research
2.4.4 Others
2.5 Zika Virus Vaccines Consumption by Application
2.5.1 Global Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Zika Virus Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Zika Virus Vaccines Sale Price by Type (2015-2020)
3 Global Zika Virus Vaccines by Company
3.1 Global Zika Virus Vaccines Sales Market Share by Company
3.1.1 Global Zika Virus Vaccines Sales by Company (2018-2020)
3.1.2 Global Zika Virus Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Zika Virus Vaccines Revenue Market Share by Company
3.2.1 Global Zika Virus Vaccines Revenue by Company (2018-2020)
3.2.2 Global Zika Virus Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Zika Virus Vaccines Sale Price by Company
3.4 Global Zika Virus Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Zika Virus Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Zika Virus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Zika Virus Vaccines by Regions
4.1 Zika Virus Vaccines by Regions
4.2 Americas Zika Virus Vaccines Consumption Growth
4.3 APAC Zika Virus Vaccines Consumption Growth
4.4 Europe Zika Virus Vaccines Consumption Growth
4.5 Middle East & Africa Zika Virus Vaccines Consumption Growth
5 Americas
5.1 Americas Zika Virus Vaccines Consumption by Countries
5.1.1 Americas Zika Virus Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Zika Virus Vaccines Value by Countries (2015-2020)
5.2 Americas Zika Virus Vaccines Consumption by Type
5.3 Americas Zika Virus Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Zika Virus Vaccines Consumption by Regions
6.1.1 APAC Zika Virus Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Zika Virus Vaccines Value by Regions (2015-2020)
6.2 APAC Zika Virus Vaccines Consumption by Type
6.3 APAC Zika Virus Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Zika Virus Vaccines by Countries
7.1.1 Europe Zika Virus Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Zika Virus Vaccines Value by Countries (2015-2020)
7.2 Europe Zika Virus Vaccines Consumption by Type
7.3 Europe Zika Virus Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Zika Virus Vaccines by Countries
8.1.1 Middle East & Africa Zika Virus Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Zika Virus Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Zika Virus Vaccines Consumption by Type
8.3 Middle East & Africa Zika Virus Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Zika Virus Vaccines Distributors
10.3 Zika Virus Vaccines Customer
11 Global Zika Virus Vaccines Market Forecast
11.1 Global Zika Virus Vaccines Consumption Forecast (2021-2025)
11.2 Global Zika Virus Vaccines Forecast by Regions
11.2.1 Global Zika Virus Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Zika Virus Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Zika Virus Vaccines Forecast by Type
11.8 Global Zika Virus Vaccines Forecast by Application
12 Key Players Analysis
12.1 NHI
12.1.1 Company Information
12.1.2 Zika Virus Vaccines Product Offered
12.1.3 NHI Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 NHI Latest Developments
12.2 Intrexon Corp.
12.2.1 Company Information
12.2.2 Zika Virus Vaccines Product Offered
12.2.3 Intrexon Corp. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Intrexon Corp. Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Zika Virus Vaccines Product Offered
12.3.3 Sanofi Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Bharat.
12.4.1 Company Information
12.4.2 Zika Virus Vaccines Product Offered
12.4.3 Bharat. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bharat. Latest Developments
12.5 Takeda
12.5.1 Company Information
12.5.2 Zika Virus Vaccines Product Offered
12.5.3 Takeda Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Takeda Latest Developments
12.6 GSK
12.6.1 Company Information
12.6.2 Zika Virus Vaccines Product Offered
12.6.3 GSK Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GSK Latest Developments
12.7 PaxVax
12.7.1 Company Information
12.7.2 Zika Virus Vaccines Product Offered
12.7.3 PaxVax Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 PaxVax Latest Developments
12.8 Inovio Pharmaceuticals
12.8.1 Company Information
12.8.2 Zika Virus Vaccines Product Offered
12.8.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Inovio Pharmaceuticals Latest Developments
12.9 Gilead Sciences Inc.
12.9.1 Company Information
12.9.2 Zika Virus Vaccines Product Offered
12.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Gilead Sciences Inc. Latest Developments
12.10 GeneOne Life Science Inc
12.10.1 Company Information
12.10.2 Zika Virus Vaccines Product Offered
12.10.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 GeneOne Life Science Inc Latest Developments
12.11 NewLink Genetics Corp
12.11.1 Company Information
12.11.2 Zika Virus Vaccines Product Offered
12.11.3 NewLink Genetics Corp Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 NewLink Genetics Corp Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Zika Virus Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of DNA Vaccine
Table 5. Major Players of Inactivated Vaccine
Table 6. Major Players of Purified Inactivated Vaccine
Table 7. Major Players of Table of Contents
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Table 10. Global Zika Virus Vaccines Revenue by Type (2015-2020) ($ million)
Table 11. Global Zika Virus Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Zika Virus Vaccines Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Table 15. Global Zika Virus Vaccines Value by Application (2015-2020)
Table 16. Global Zika Virus Vaccines Value Market Share by Application (2015-2020)
Table 17. Global Zika Virus Vaccines Sale Price by Application (2015-2020)
Table 18. Global Zika Virus Vaccines Sales by Company (2017-2019) (MT)
Table 19. Global Zika Virus Vaccines Sales Market Share by Company (2017-2019)
Table 20. Global Zika Virus Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Zika Virus Vaccines Revenue Market Share by Company (2017-2019)
Table 22. Global Zika Virus Vaccines Sale Price by Company (2017-2019)
Table 23. Global Zika Virus Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Zika Virus Vaccines Products Offered
Table 25. Zika Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Zika Virus Vaccines Consumption by Regions 2015-2020 (MT)
Table 27. Global Zika Virus Vaccines Consumption Market Share by Regions 2015-2020
Table 28. Global Zika Virus Vaccines Value by Regions 2015-2020 ($ Millions)
Table 29. Global Zika Virus Vaccines Value Market Share by Regions 2015-2020
Table 30. Americas Zika Virus Vaccines Consumption by Countries (2015-2020) (MT)
Table 31. Americas Zika Virus Vaccines Consumption Market Share by Countries (2015-2020)
Table 32. Americas Zika Virus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Zika Virus Vaccines Value Market Share by Countries (2015-2020)
Table 34. Americas Zika Virus Vaccines Consumption by Type (2015-2020) (MT)
Table 35. Americas Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Table 36. Americas Zika Virus Vaccines Consumption by Application (2015-2020) (MT)
Table 37. Americas Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Table 38. APAC Zika Virus Vaccines Consumption by Regions (2015-2020) (MT)
Table 39. APAC Zika Virus Vaccines Consumption Market Share by Regions (2015-2020)
Table 40. APAC Zika Virus Vaccines Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Zika Virus Vaccines Value Market Share by Regions (2015-2020)
Table 42. APAC Zika Virus Vaccines Consumption by Type (2015-2020) (MT)
Table 43. APAC Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Table 44. APAC Zika Virus Vaccines Consumption by Application (2015-2020) (MT)
Table 45. APAC Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Table 46. Europe Zika Virus Vaccines Consumption by Countries (2015-2020) (MT)
Table 47. Europe Zika Virus Vaccines Consumption Market Share by Countries (2015-2020)
Table 48. Europe Zika Virus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Zika Virus Vaccines Value Market Share by Countries (2015-2020)
Table 50. Europe Zika Virus Vaccines Consumption by Type (2015-2020) (MT)
Table 51. Europe Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Table 52. Europe Zika Virus Vaccines Consumption by Application (2015-2020) (MT)
Table 53. Europe Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Zika Virus Vaccines Consumption by Countries (2015-2020) (MT)
Table 55. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Zika Virus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Zika Virus Vaccines Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Zika Virus Vaccines Consumption by Type (2015-2020) (MT)
Table 59. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Zika Virus Vaccines Consumption by Application (2015-2020) (MT)
Table 61. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Table 62. Zika Virus Vaccines Distributors List
Table 63. Zika Virus Vaccines Customer List
Table 64. Global Zika Virus Vaccines Consumption Forecast by Countries (2021-2025) (MT)
Table 65. Global Zika Virus Vaccines Consumption Market Forecast by Regions
Table 66. Global Zika Virus Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Zika Virus Vaccines Value Market Share Forecast by Regions
Table 68. Global Zika Virus Vaccines Consumption Forecast by Type (2021-2025) (MT)
Table 69. Global Zika Virus Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Zika Virus Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Zika Virus Vaccines Value Market Share Forecast by Type (2021-2025)
Table 72. Global Zika Virus Vaccines Consumption Forecast by Application (2021-2025) (MT)
Table 73. Global Zika Virus Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Zika Virus Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Zika Virus Vaccines Value Market Share Forecast by Application (2021-2025)
Table 76. NHI Product Offered
Table 77. NHI Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 78. NHI Main Business
Table 79. NHI Latest Developments
Table 80. NHI Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Intrexon Corp. Product Offered
Table 82. Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 83. Intrexon Corp. Main Business
Table 84. Intrexon Corp. Latest Developments
Table 85. Intrexon Corp. Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Product Offered
Table 87. Sanofi Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Sanofi Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Bharat. Product Offered
Table 92. Bharat. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 93. Bharat. Main Business
Table 94. Bharat. Latest Developments
Table 95. Bharat. Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Takeda Product Offered
Table 97. Takeda Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 98. Takeda Main Business
Table 99. Takeda Latest Developments
Table 100. Takeda Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. GSK Product Offered
Table 102. GSK Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 103. GSK Main Business
Table 104. GSK Latest Developments
Table 105. GSK Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. PaxVax Product Offered
Table 107. PaxVax Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. PaxVax Main Business
Table 109. PaxVax Latest Developments
Table 110. PaxVax Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Inovio Pharmaceuticals Product Offered
Table 112. Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 113. Inovio Pharmaceuticals Main Business
Table 114. Inovio Pharmaceuticals Latest Developments
Table 115. Inovio Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Gilead Sciences Inc. Product Offered
Table 117. Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 118. Gilead Sciences Inc. Main Business
Table 119. Gilead Sciences Inc. Latest Developments
Table 120. Gilead Sciences Inc. Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. GeneOne Life Science Inc Product Offered
Table 122. GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 123. GeneOne Life Science Inc Main Business
Table 124. GeneOne Life Science Inc Latest Developments
Table 125. GeneOne Life Science Inc Basic Information, Company Total Revenue (in $ million), Zika Virus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. NewLink Genetics Corp Product Offered
Table 127. NewLink Genetics Corp Zika Virus Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 128. NewLink Genetics Corp Main Business
Table 129. NewLink Genetics Corp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. NewLink Genetics Corp Latest Developments
List of Figures
Figure 1. Picture of Zika Virus Vaccines
Figure 2. Zika Virus Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Zika Virus Vaccines Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Zika Virus Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of DNA Vaccine
Figure 7. Product Picture of Inactivated Vaccine
Figure 8. Product Picture of Purified Inactivated Vaccine
Figure 9. Product Picture of Table of Contents
Figure 10. Global Zika Virus Vaccines Consumption Market Share by Type (2015-2020)
Figure 11. Global Zika Virus Vaccines Value Market Share by Type (2015-2020)
Figure 12. Zika Virus Vaccines Consumed in Hospitals
Figure 13. Global Zika Virus Vaccines Market: Hospitals (2015-2020) (MT)
Figure 14. Global Zika Virus Vaccines Market: Hospitals (2015-2020) ($ Millions)
Figure 15. Zika Virus Vaccines Consumed in Clinics
Figure 16. Global Zika Virus Vaccines Market: Clinics (2015-2020) (MT)
Figure 17. Global Zika Virus Vaccines Market: Clinics (2015-2020) ($ Millions)
Figure 18. Zika Virus Vaccines Consumed in Academic and Research
Figure 19. Global Zika Virus Vaccines Market: Academic and Research (2015-2020) (MT)
Figure 20. Global Zika Virus Vaccines Market: Academic and Research (2015-2020) ($ Millions)
Figure 21. Zika Virus Vaccines Consumed in Others
Figure 22. Global Zika Virus Vaccines Market: Others (2015-2020) (MT)
Figure 23. Global Zika Virus Vaccines Market: Others (2015-2020) ($ Millions)
Figure 24. Global Zika Virus Vaccines Consumption Market Share by Application (2015-2020)
Figure 25. Global Zika Virus Vaccines Value Market Share by Application (2015-2020)
Figure 26. Global Zika Virus Vaccines Sales Market Share by Company in 2017
Figure 27. Global Zika Virus Vaccines Sales Market Share by Company in 2019
Figure 28. Global Zika Virus Vaccines Revenue Market Share by Company in 2017
Figure 29. Global Zika Virus Vaccines Revenue Market Share by Company in 2019
Figure 30. Global Zika Virus Vaccines Sale Price by Company in 2019
Figure 31. Global Zika Virus Vaccines Consumption Market Share by Regions 2015-2020
Figure 32. Global Zika Virus Vaccines Value Market Share by Regions 2015-2020
Figure 33. Americas Zika Virus Vaccines Consumption 2015-2020 (MT)
Figure 34. Americas Zika Virus Vaccines Value 2015-2020 ($ Millions)
Figure 35. APAC Zika Virus Vaccines Consumption 2015-2020 (MT)
Figure 36. APAC Zika Virus Vaccines Value 2015-2020 ($ Millions)
Figure 37. Europe Zika Virus Vaccines Consumption 2015-2020 (MT)
Figure 38. Europe Zika Virus Vaccines Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Zika Virus Vaccines Consumption 2015-2020 (MT)
Figure 40. Middle East & Africa Zika Virus Vaccines Value 2015-2020 ($ Millions)
Figure 41. Americas Zika Virus Vaccines Consumption Market Share by Countries in 2019
Figure 42. Americas Zika Virus Vaccines Value Market Share by Countries in 2019
Figure 43. Americas Zika Virus Vaccines Consumption Market Share by Type in 2019
Figure 44. Americas Zika Virus Vaccines Consumption Market Share by Application in 2019
Figure 45. United States Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 46. United States Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 48. Canada Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 50. Mexico Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Zika Virus Vaccines Consumption Market Share by Countries in 2019
Figure 52. APAC Zika Virus Vaccines Value Market Share by Regions in 2019
Figure 53. APAC Zika Virus Vaccines Consumption Market Share by Type in 2019
Figure 54. APAC Zika Virus Vaccines Consumption Market Share by Application in 2019
Figure 55. China Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 56. China Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 58. Japan Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 60. Korea Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 62. Southeast Asia Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 63. India Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 64. India Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 66. Australia Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Zika Virus Vaccines Consumption Market Share by Countries in 2019
Figure 68. Europe Zika Virus Vaccines Value Market Share by Countries in 2019
Figure 69. Europe Zika Virus Vaccines Consumption Market Share by Type in 2019
Figure 70. Europe Zika Virus Vaccines Consumption Market Share by Application in 2019
Figure 71. Germany Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 72. Germany Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. France Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 74. France Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. UK Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 76. UK Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 78. Italy Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 80. Russia Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Zika Virus Vaccines Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Zika Virus Vaccines Consumption Market Share by Application in 2019
Figure 85. Egypt Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 86. Egypt Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 88. South Africa Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 90. Israel Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 92. Turkey Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Zika Virus Vaccines Consumption Growth 2015-2020 (MT)
Figure 94. GCC Countries Zika Virus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 95. Global Zika Virus Vaccines Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 96. Global Zika Virus Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 98. Americas Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 99. APAC Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 100. APAC Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 101. Europe Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 102. Europe Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 104. Middle East & Africa Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 105. United States Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 106. United States Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 107. Canada Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 108. Canada Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 109. Mexico Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 110. Mexico Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 111. Brazil Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 112. Brazil Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 113. China Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 114. China Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 115. Japan Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 116. Japan Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 117. Korea Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 118. Korea Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 120. Southeast Asia Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 121. India Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 122. India Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 123. Australia Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 124. Australia Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 125. Germany Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 126. Germany Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 127. France Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 128. France Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 129. UK Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 130. UK Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 131. Italy Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 132. Italy Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 133. Russia Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 134. Russia Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 135. Spain Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 136. Spain Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 137. Egypt Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 138. Egypt Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 139. South Africa Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 140. South Africa Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 141. Israel Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 142. Israel Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 143. Turkey Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 144. Turkey Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Zika Virus Vaccines Consumption 2021-2025 (MT)
Figure 146. GCC Countries Zika Virus Vaccines Value 2021-2025 ($ Millions)
Figure 147. NHI Zika Virus Vaccines Market Share (2018-2020)
Figure 148. Intrexon Corp. Zika Virus Vaccines Market Share (2018-2020)
Figure 149. Sanofi Zika Virus Vaccines Market Share (2018-2020)
Figure 150. Bharat. Zika Virus Vaccines Market Share (2018-2020)
Figure 151. Takeda Zika Virus Vaccines Market Share (2018-2020)
Figure 152. GSK Zika Virus Vaccines Market Share (2018-2020)
Figure 153. PaxVax Zika Virus Vaccines Market Share (2018-2020)
Figure 154. Inovio Pharmaceuticals Zika Virus Vaccines Market Share (2018-2020)
Figure 155. Gilead Sciences Inc. Zika Virus Vaccines Market Share (2018-2020)
Figure 156. GeneOne Life Science Inc Zika Virus Vaccines Market Share (2018-2020)
Figure 157. NewLink Genetics Corp Zika Virus Vaccines Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
